Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges

Abstract

Cancer development and progression of cancer is closely associated with the activation of oncogenes and loss of tumor suppressor genes. Nucleic acid drugs (e.g., siRNA, mRNA, and DNA) have been widely used for cancer therapy due to their specific ability to regulate the expression of any cancer‐associated genes. However, nucleic acid drugs are negatively charged biomacromolecules that are susceptible to serum nucleases and could not cross cell membrane. Therefore, specific delivery tools are required to facilitate the intracellular delivery of nucleic acid drugs. In the past few decades, a variety of nanoparticles (NPs) have been designed and developed for nucleic acid delivery and cancer therapy. In particular, the polymeric NPs in response to the abnormal redox status in cancer cells have garnered much more attention as their potential in redox‐triggered nanostructure dissociation and rapid intracellular release of nucleic acid drugs. In this review, we briefly introduce the important genes or signaling pathways regulating the abnormal redox status in cancer cells and systemically summarize the recent development of redox‐responsive NPs for nucleic acid delivery and cancer therapy. We also discuss the future development of NPs‐mediated nucleic acid delivery and their challenges in clinical translation.This article is protected by copyright. All rights reserved

Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy

“…The selenium-containing polymers and selenium such as sulfur can result in the development of bonds sensitive to redox. In the recent years, the redox-responsive nanoparticles have been extensively used in the treatment of cancer [176] , [177] , [178] , [179] , [180] . There are several advantageous regarding targeting GSH for cancer therapy.…”

Nature-inspired protein mineralization strategies for nanoparticle construction: advancing effective cancer therapy

“…[6][7][8] In the target tumor tissue and tumor cells, NPs can also achieve sustained and controlled drug release by modifying their drug release mechanisms, thereby enhancing the treatment efficacy. [9][10][11] In addition, NPs can integrate multiple treatment modalities into a single nano-system, enabling multifunctional therapy such as combination chemotherapy and photothermal therapy. 12,13 To date, the commonly explored NP carriers mainly include lipid carriers, [14][15][16] polymer macromolecules, 17,18 mesoporous silica nanoparticles, [19][20][21] cell membranes, [22][23][24] metal-organic framework (MOF) nano-delivery systems, and protein drug carriers.…”